<<
>>

.. . , , 1998; 420 .

.. . . . 33. , , 1978, .

5-68.

. . // , 1987. 2. . 30-35.

.. . (- 8), , . , 17-23 2010 .

.., .. . , .4., 2, 2010, . 25-35.

Anderson JS, Nettleton JA, Herrington DM. Relation of omega-3 fatty acid and dietary fish intake with brachial artery flow-mediated vasodilation in the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr. 2010;92(5):1204-13.

Arnold C, KonkelA, Fischer R, Schunck WH. Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids. Pharmacol Rep. 2010;62(3):536-547.

Arnold C, Markovic M, Blossey K, Wallukat G, Fischer R, Dechend R, Konkel A, von Schacky C, Luft FC, Muller DN, Rothe M, Schunck WH. Arachidonic acid- metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids. J Biol Chem. 2010;285(43):32720-33

Bacova B, Radosinska J, Knezl V, Kolenova L, Weismann P, Navarova J, Barancik M, Mitasikova M, Tribulova N. Omega-3 fatty acids and atorvastatin suppress ventricular fibrillation inducibility in hypertriglyceridemic rat hearts: implication of intracellular coupling protein, connexin-43. J Physiol Pharmacol. 2010;61(6):717-723.

Banchs JE, Wolbrette DL, Samii SM, Penny-Peterson ED, Patel PP, Young SK, Gonzalez MD, Naccarelli GV. Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter. J Interv Card Electrophysiol. 2008 Nov;23(2):111-5. Epub 2008 Aug 8.

Bazan NG. Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr Opin Clin Nutr Metab Care. 2007;10(2):136-141.

Berry JD, Prineas RJ, van Horn L, Passman R, Larson J, Goldberger J, Snetselaar L, Tinker L, Liu K, Lloyd-Jones DM. Dietary fish intake and incident atrial fibrillation (from the Womens Health Initiative). Am J Cardiol. 2010;105(6):844-848.

Borjesson SI, Hammarstrom S, Elinder F. Lipoelectric modification of ion channel voltage gating by polyunsaturated fatty acids. Biophys J. 2008;95(5):2242-53 Epub 2008 M.

Bos CL, Richel DJ, Ritsema T, Peppelenbosch MP, Versteeg HH. Prostanoids and prostanoid receptors in signal transduction. Int J Biochem Cell Biol. 2004;36(7):1187-1205.

Brink C, Dahlen SE, Drazen J, Evans JF, Hay DW, Nicosia S, Serhan CN, Shimizu T, Yokomizo T. International Union of PharmacologyXXXVII. Nomenclature for leukotriene and lipoxin receptors.

Pharmacol Rev. 2003;55(1):195-227.

Brouwer IA, Raitt MH, Dullemeijer C, Kraemer DF, Zock PL, Morris C, Katan MB, Connor WE, Camm JA, Schouten EG, McAnulty J. Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators. Eur Heart J. 2009;30(7):820-6

Brouwer IA, Zock PL, Camm AJ. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA. 2006;295(22):2613-2619.

Calder PC, Yaqoob P. Omega-3 (n-3) fatty acids, cardiovascular disease and stability of atherosclerotic plaques. Cell Mol Biol (Noisy-le-grand). 2010;56(1):28-37.

Calo L, Bianconi L, Colivicchi F, Lamberti F, Loricchio ML, de Ruvo E, Meo A, Pandozi C, Staibano M, Santini M. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol. 2005;45(10):1723-1728.

Calo L, Martino A, Sciarra L, Ciccaglioni A, De Ruvo E, De Luca L, Sette A, Giunta G, Lioy E, Fedele F. Upstream effect for atrial fibrillation: still a dilemma? Pacing Clin Electrophysiol. 2011;34(1):111 -28 doi.

Campbell WB, Falck JR.Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors.Hypertension. 2007 Mar;49(3):590-6.

Chrysohoou C, Panagiotakos DB, Pitsavos C. Long-term fish consumption is associated with protection against arrhythmia in healthy persons in a Mediterranean region--the ATTICA study. Am J Clin Nutr. 2007;85(5):1385-1391.

Coleman RA, Smith WL, Narumiya S. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev. 1994;46(2):205-229.

Das UN. Beneficial effect(s) of n-3 fatty acids in cardiovascular diseases: but, why and how? Prostaglandins Leukot Essent Fatty Acids. 2000;63(6):351 -362.

de Berrazueta JR, Gomez de Berrazueta JM. A diet enriched with mackerel (Scomber scombrus)-derived products improves the endothelial function in a senior population (Prevencion de las Enfermedades Cardiovasculares: Estudio Santona--PECES project). Eur J Clin Invest. 2009;39(3):165-173.

Den Ruijter HM, Berecki G, Verkerk AO. Acute administration of fish oil inhibits triggered activity in isolated myocytes from rabbits and patients with heart failure. Circulation. 2008;117(4):536-44.

Di Minno MN, Tremoli E, Tufano A, Russolillo A, Lupoli R, Di Minno G. Exploring newer cardioprotective strategies: omega-3 fatty acids in perspective. Thromb Haemost. 2010;104(4):664-80.

Dobrev D, Nattel S. New antiarrhythmic drugs for treatment of atrial fibrillation. Lancet. 2010;375(9721):1212-23.

Dujardin KS, Dumotier B, David M, Guizy M, Valenzuela C, Hondeghem LM. Ultrafast sodium channel block by dietary fish oil prevents dofetilide-in- duced ventricular arrhythmias in rabbit hearts. Am J Physiol Heart Circ Physiol. 2008;295(4):H1414-21.

Ebbesson SO, Devereux RB, Cole S, Ebbesson LO. Heart rate is associated with red blood cell fatty acid concentration: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study. Am Heart J. 2010;159(6):1020-1 025.20.

Eid HM, Arnesen H, Hjerkinn EM, Lyberg T, Ellingsen I, Seljeflot I. Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine. Nutr Metab (Lond). 2006;3:4.

Engler MB, Ma YH, Engler MM. Calcium-mediated mechanisms of eicosa- pentaenoic acid-induced relaxation in hypertensive rat aorta. Am J Hypertens. 1999;12(12 Pt 1:1225-1235.

Engler MB. Effects of omega-3, omega-6 and omega-9 fatty acids on vascular smooth muscle tone. Eur J Pharmacol. 1992;215(2-3):325-328.

Fabre J.E., Nguyen M, Athirakul K, Coggins K, McNeish JD, Austin S, Parise LK, FitzGerald GA, Coffman TM, Koller BH. Journal of Clinical investigation, 2001, 107:603

Frost L, Vestergaard P. n-3 Fatty acids consumed from fish and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Clin Nutr. 2005;81(1):50-54.

GISSI Study Group. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nellInfarto miocardico. Lancet. 1999;354(9177):447-455.

Goodfellow J, Bellamy MF, Ramsey MW, Jones CJ, Lewis MJ. Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. J Am Coll Cardiol. 2000;35(2):265-270.

Gross S., Tilly P., Hentsch D., Vonesch J.L., Fabre J.E. Journal of Experimental Medicine, 2007, 204:311

Harris WS, Von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med. 2004;39(1):212-220.

Heidarsdottir R, Arnar DO, Skuladottir GV, Torfason B, Edvardsson V, Gott- skalksson G, Palsson R, Indridason OS. Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery? Europace. 2010;12(3):356-63.

Hirafuji M, Machida T, Hamaue N, Minami M. Cardiovascular protective effects of n-3 polyunsaturated fatty acids with special emphasis on docosahexae- noic acid. J Pharmacol Sci. 2003;92(4):308-316.

Ioannidis JP. Why most published research findings are false. PLoS Med. 2005;2(8):e124

Kowey PR, Reiffel JA, Ellenbogen KA, Naccarelli GV, Pratt CM. Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial. JAMA. 2010;304(21):2363-72

Lau DH, Psaltis PJ, Carbone A. Atrial protective effects of n-3 polyunsaturated fatty acids: A long-term study in ovine chronic heart failure. Heart Rhythm. 2010;Heart Rhyt.

Lavie CJ, Milani RV, Mehra MR, Ventura HO. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol. 2009;54(7):585-594.

Lawson DL, Mehta JL, Saldeen K, Mehta P, Saldeen TG. Omega-3 polyunsaturated fatty acids augment endothelium-dependent vasorelaxation by enhanced release of EDRF and vasodilator prostaglandins. Eicosanoids. 1991;4(4):217-223.

Leaf A, Albert CM, Josephson M, Steinhaus D, Kluger J, Kang JX, Cox B, Zhang H, Schoenfeld D. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation. 2005;112(18):2762-2768.

Li X, Hong S, Li PL, Zhang Y. Docosahexanoic Acid-Induced Coronary Arterial Dilation: Actions of 17S-Hydroxy Docosahexanoic Acid on K+ Channel Activity. J Pharmacol Exp Ther. 2011;336(3):891-9.

Lu T, VanRollins M, Lee HC. Stereospecific activation of cardiac ATP-sensi- tive K(+) channels by epoxyeicosatrienoic acids: a structural determinant study. Mol Pharmacol. 2002;62(5):1076-1083.

Macchia A, Monte S, Pellegrini F, Romero M, Ferrante D, Doval H, DEttorre A, Maggioni AP, Tognoni G. Omega-3 fatty acid supplementation reduces one- year risk of atrial fibrillation in patients hospitalized with myocardial infarction. Eur J Clin Pharmacol. 2008;64(6):627-634.

Marchioli R, Barzi F, Bomba E; GISSI-Prevenzione Investigators.Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nellInfarto Miocardico (GISSI)-Prevenzione.Circulation. 2002Apr 23;105(16):1897-903.

Marchioli R, Levantesi G, Macchia A, Maggioni AP, Marfisi RM, Silletta MG, Tavazzi L, Tognoni G, Valagussa F. Antiarrhythmic mechanisms of n-3 PUFA and the results of the GISSI-Prevenzione trial. J Membr Biol. 2005;206(2):117-128.

Marchioli R, Marfisi RM, Borrelli G, Chieffo C, Franzosi MG, Levantesi G, Maggioni AP, Nicolosi GL, Scarano M, Silletta MG, Schweiger C, Tavazzi

L, Tognoni G. Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial. J Cardiovasc Med (Hagerstown). 2007;8 Suppl 1: S34-S37.

Mariscalco G, Sarzi Braga S, Banach M, Borsani P, Bruno VD, Napoleone

M, Vitale C, Piffaretti G, Pedretti RF, Sala A. Preoperative n-3 polyunsatured fatty acids are associated with a decrease in the incidence of early atrial fibrillation following cardiac surgery. Angiology. 2010;61(7):643-50 Epub 2010 Ju.

McGiff JC, Quilley J.20-HETE and the kidney: resolution of old problems and newbeginnings.Am J Physiol. 1999 Sep;277(3 Pt 2):R607-23.

Mori TA. Omega-3 fatty acids and blood pressure. Cell Mol Biol (Noisy-le- grand). 2010;56(1):83-92.

Morin C, Sirois M, Echave V, Rizcallah E, Rousseau E. Relaxing effects of 17(18)-EpETE on arterial and airway smooth muscles in human lung. Am J Physiol Lung Cell Mol Physiol. 2009;296(1):L130-9.

Mozaffarian D, Prineas RJ, Stein PK, Siscovick DS. Dietary fish and n-3 fatty acid intake and cardiac electrocardiographic parameters in humans. J Am Coll Cardiol. 2006;48(3):478-84.

Mozaffarian D, Psaty BM, Rimm EB, Lemaitre RN, Burke GL, Lyles MF, Lefkowitz D, Siscovick DS. Fish intake and risk of incident atrial fibrillation. Circulation. 2004;110(4):368-73.

Patel C, Yan GX, Kowey PR.Dronedarone. Circulation. 2009 Aug 18;120(7):636-44.

Patel D, Shaheen M, Venkatraman P, Armaganijan L, Sanchez JE, Horton RP, Di Biase L, Mohanty P, Canby R, Bailey SM, Burkhardt JD, Gallinghouse GJ, Zagrodzky JD, Kozeluhova M, Natale A. Omega-3 polyunsaturated Fatty Acid supplementation reduced atrial fibrillation recurrence a fter pulmonary vein antrum isolation. Indian Pacing Electrophysiol J. 2009;9(6):292-298.

Pratt CM, Roy D, Torp-Pedersen C, Wyse DG, Toft E, Juul-Moller S, Retyk E, Drenning DH; Atrial Arrhythmia Conversion Trial (ACT-III) Investigators. Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation. Am J Cardiol. 2010 Nov 1;106(9):1277-83.

Raatikainen MJ, Huikuri HV. New antiarrhythmic drugs for treatment of atrial fibrillation. Duodecim. 2010;126(19):2255-2262.

-3 nHMK u apumMua - e noucKax 83auMocea3u

Ramadeen A, Laurent G, dos Santos CC, Hu X, Connelly KA, Holub BJ, Mangat I, Dorian P. n-3 Polyunsaturated fatty acids alter expression of fibrotic and hypertrophic genes in a dog model of atrial cardiomyopathy. Heart Rhythm. 2010;7(4):520-8.

Rang H.P. Pharmacology (5th ed.). Edinburgh: Churchill Livingstone. 2003. pp. 234. ISBN 0-443-07145-4.

Reiffel JA.Atrial fibrillation: what have recent trials taught us regarding pharmacologic management of rate and rhythm control? Pacing Clin Electrophysiol. 2011 Feb;34(2):247-59.

Richardson ES, laizzo PA, Xiao YF. Electrophysiological mechanisms of the anti-arrhythmic effects of omega-3 fatty acids. J Cardiovasc Transl Res. 2011;4(1):42-52.

Rupp H. Omacor (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia. Adv Ther. 2009;26(7):675-90

Santangeli P, Biase LD, Pelargonio G, Burkhardt JD, Natale A. The pharmaceutical pipeline for atrial fibrillation. Ann Med. 2011;43( 1):13-32.

Saravanan P, Bridgewater B, West AL, ONeill SC, Calder PC, Davidson NC. Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. Circ Arrhythm Electrophysiol. 2010;3(1):46-53.

Saravanan P, Davidson NC, Schmidt eB, Calder PC. Cardiovascular effects of marine omega-3 fatty acids. Lancet. 2010;376(9740):540-50.

Serhan CN, Chiang N, Van Dyke TE.Resolving inflammation: dual antiinflammatory and pro-resolution lipid mediators.Nat Rev Immunol. 2008 May;8(5):349-61.

Seubert JM, Zeldin DC, Nithipatikom K, Gross GJ.Role of epoxyeicosatri- enoic acids in protecting the myocardium following ischemia/reperfusion injury. Prostaglandins Other Lipid Mediat. 2007 Jan;82(1 -4):50-9.

Smith PJ, Blumenthal JA, Babyak MA, Georgiades A, Sherwood A, Sketch MH Jr, Watkins LL. Association between n-3 fatty acid consumption and ventricular ectopy after myocardial infarction. Am J Clin Nutr. 2009;89(5):1315-20.

Tatarczyk T, Engl J, Ciardi C, Laimer M, Kaser S, Salzmann K, Lenners R, Patsch JR, Ebenbichler CF. Analysis of long-chain omega-3 fatty acid content in fish-oil supplements. Wien Klin Wochenschr. 2007;119(13-14):417-422.

Torshin I.Yu. Bioinformatics in the post-genomic era: physiology and medicine. Nova Biomedical, ISBN 9781600 217524, 2007, 300pp.

Torshin I.Yu. Bioinformatics in the post-genomic era: sensing the change from molecular genetics to personalized medicine. Nova Biomedical Books, NY, USA, 2009, In Bioinformatics in the Post-Genomic Era series, ISBN: 978-1-60692-217-0.

Virtanen JK, Mursu J, Voutilainen S, Tuomainen TP. Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men. Circulation. 2009;120(23):2315-21.

von Schacky C. Omega-3 fatty acids: antiarrhythmic, proarrhythmic or both? Curr Opin Clin Nutr Metab Care. 2008;11(2):94-99.

Wada M, DeLong CJ, Hong YH, Rieke CJ. Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid- derived substrates and products. J Biol Chem. 2007 Aug 3;282(31):22254-66.

Wang RX, LiXR, Guo T, Sun LP, Guo SX, Yang ZY, Yang XJ, Jiang WP. Doco- sahexaenoic acid has influence on action potentials and transient outward potassium currents of ventricular myocytes. Lipids Health Dis. 2010;9:39.

Wann LS, Curtis AB, Ellenbogen KA, Estes NA 3rd, Ezekowitz MD, Jackman WM, January CT, Lowe JE, Page RL, Slotwiner DJ, Stevenson WG, Tracy CM. 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.Circulation. 2011 Feb 14

Xiao YF, Ke Q, Chen Y, Morgan JP, Leaf A. Inhibitory effect of n-3 fish oil fatty acids on cardiac Na+/Ca2+ exchange currents in HEK293t cells. Biochem Biophys Res Commun. 2004;321(1):116-123.

Xiao YF, Ma L, Wang SY, Josephson ME, Wang GK, Morgan JP, Leaf A. Potent block of inactivation-deficient Na+ channels by n-3 polyunsaturated fatty acids. Am J Physiol Cell Physiol. 2006;290(2):C362-70.

Zeldin DC.Epoxygenase pathways of arachidonic acid metabolism.J Biol Chem. 2001 Sep 28;276(39):36059-62. Epub 2001 Jul 12.

<< | >>
: . ., . .. - 61 . - .: , 2012- 747 .. 2012

:

- -
- - - - - - - - - - - - - -